Overview
Cytiva provides technologies and services for bioprocessing, including single-use systems, modular facilities, and automation tools to accelerate therapeutic development and manufacturing. Their portfolio features brands like ÄKTA, HyClone, and MabSelect, supporting upstream and downstream workflows with digital integration for efficiency and compliance. Enterprise solutions such as BioPark, KUBio, and FlexFactory enable scalable biomanufacturing and cell therapy production.
Frequently asked questions
- What bioprocessing technologies does Cytiva offer?
- Cytiva offers single-use systems, chromatography products like ÄKTA and MabSelect, cell culture media from HyClone, modular facilities like BioPark and KUBio, and configurable platforms like FlexFactory for biomanufacturing and cell therapy.
- Does Cytiva provide regulatory-compliant solutions?
- Yes, Cytiva's solutions support compliance through automated eCoA import, lot genealogy data entry, and integration with Quality Management Systems, reducing errors and accelerating raw material release in bioprocessing workflows.
- What are Cytiva's global capabilities and services?
- Cytiva delivers global technologies for research and manufacturing, including process development services, digital data bridges for analytics, and enterprise solutions adaptable to biopharma demands across geographies.